April M Weissmiller

13PUBLICATIONS
32CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 11, 2026
Novel Triazoloquinoxaline-Based Tubulin Polymerization Inhibitor Induces Necroptosis and Significantly Inhibits Metastatic Melanoma Tumor Growth.

Christopher J Clark, Shelby N Waddell, Garrett E Tessmer

|May 28, 2025
Colchicine Binding Site Tubulin Inhibitors Impair Vincristine-Resistant Neuroblastoma Cell Function.

Cinthia N Reed, Kaylee B Garrison, Joshua Thammathong

|Jan 25, 2025
Structure-Based Discovery of MolPort-137: A Novel Autotaxin Inhibitor That Improves Paclitaxel Efficacy.

Prateek Rai, Christopher J Clark, Vandana Kardam

|Sep 28, 2024
Novel Autotaxin Inhibitor ATX-1d Significantly Enhances Potency of Paclitaxel-An In Silico and In Vitro Study.

Prateek Rai, Christopher J Clark, Carl B Womack

|Aug 21, 2024
Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies.

Christian T Meyer, Brianna N Smith, Jing Wang

Pageof 3